Importantly, CUR demonstrates anticancer properties by reducing the expression of various growth factors and their receptors, cytokines, enzymes, and reactive oxygen species, and also by impairing oncogenic pathways frequently activated during cancer progression, such as TGF-β, AKT/mTOR, and NF-κB [16,17,18]. Here, AKT1 is linked to cancer.